PELA', Michela
 Distribuzione geografica
Continente #
NA - Nord America 1.125
EU - Europa 445
AS - Asia 215
Totale 1.785
Nazione #
US - Stati Uniti d'America 1.110
PL - Polonia 136
CN - Cina 113
UA - Ucraina 73
DE - Germania 64
SG - Singapore 60
GB - Regno Unito 54
IT - Italia 51
TR - Turchia 27
FI - Finlandia 21
CA - Canada 15
NO - Norvegia 13
SE - Svezia 13
BE - Belgio 12
JP - Giappone 3
NL - Olanda 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
TW - Taiwan 2
VN - Vietnam 2
ES - Italia 1
FR - Francia 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
MD - Moldavia 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
Totale 1.785
Città #
Warsaw 136
Ann Arbor 115
Woodbridge 115
Fairfield 98
Jacksonville 90
Houston 79
Chandler 73
Santa Clara 68
Ashburn 64
Seattle 57
Singapore 49
Wilmington 47
Beijing 41
Cambridge 36
Munich 22
Mcallen 19
Boardman 17
Izmir 17
Princeton 16
Nanjing 14
Shanghai 14
Dearborn 13
Montréal 13
Oslo 13
Brussels 12
Ferrara 12
Falls Church 10
New York 9
Auburn Hills 8
Milan 8
San Diego 8
Bremen 6
Helsinki 6
Los Angeles 6
Tianjin 6
Cagliari 5
Nanchang 5
Shenyang 5
Changsha 4
Jinan 4
Redwood City 4
Addison 3
Hefei 3
Modena 3
Mountain View 3
Walnut 3
Bologna 2
Des Moines 2
Dong Ket 2
Indiana 2
Jakarta 2
Jiaxing 2
Ningbo 2
Oderzo 2
Orange 2
Redmond 2
Scorzè 2
Zhengzhou 2
Arsiero 1
Bonn 1
Brno 1
Chengdu 1
Chisinau 1
College Station 1
Davao City 1
Falkenstein 1
Frankfurt am Main 1
Freiburg 1
Goran 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hebei 1
Islington 1
Kunming 1
Leicester 1
Leiden 1
Madrid 1
Napoli 1
Norwalk 1
Ottawa 1
Padova 1
Philadelphia 1
Portici 1
Saidu Sharif 1
San Mateo 1
Sanwal 1
Shaoxing 1
Taipei 1
Taizhou 1
Tappahannock 1
Terzigno 1
Tokyo 1
Toronto 1
Wandsworth 1
Totale 1.420
Nome #
Enantioselective Approaches and Domino Sequences for the Synthesis of Compounds of Biological Interest 237
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 171
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 155
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 137
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 123
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 110
Proteomic approach to the identification of early phase biomarker for anticancer peptides targeting thefolate pathway 106
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 103
Mastering chiral substituted 2-oxopiperazines 101
null 87
Designing a new bioconjugate FA-LR and studies of the effects in human ovarian cancer cell lines 84
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 81
A proteomic approach to investigate the mechanism of action of anticancer peptides 77
PTEROATE-PEPTIDE BIOCONJUGATE TARGETING THE FOLATE RECEPTOR IN HUMAN OVARIAN CANCER CELL LINES: TRANSPORT AND MECHANISM OF ACTION. 67
Synthesis of folic conjugated LR octapeptide 60
null 42
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 36
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 23
Totale 1.800
Categoria #
all - tutte 7.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 0 37 41 36 56 41 17
2020/2021254 26 25 17 31 20 29 11 23 7 27 27 11
2021/2022162 14 21 10 6 9 11 12 7 5 13 13 41
2022/2023199 22 8 7 22 34 29 9 14 36 0 9 9
2023/2024105 7 11 8 0 6 12 4 25 1 1 2 28
2024/2025172 14 11 35 19 51 40 2 0 0 0 0 0
Totale 1.800